{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:16:00Z","timestamp":1786986960788,"version":"build-2736575974"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004410","name":"European Molecular Biology Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005771","name":"Dokuz Eyl\u00fcl \u00dcniversitesi","doi-asserted-by":"publisher","award":["KB.SAG.109"],"award-info":[{"award-number":["KB.SAG.109"]}],"id":[{"id":"10.13039\/501100005771","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005771","name":"Dokuz Eyl\u00fcl \u00dcniversitesi","doi-asserted-by":"publisher","award":["2018186"],"award-info":[{"award-number":["2018186"]}],"id":[{"id":"10.13039\/501100005771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.clim.2022.108997","type":"journal-article","created":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T11:57:37Z","timestamp":1649332657000},"page":"108997","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Global hypomethylation pattern in systemic sclerosis: An application for absolute quantification of epigenetic DNA modification products by 2D-UPLC-MS\/MS"],"prefix":"10.1016","volume":"239","author":[{"given":"Nazl\u0131 Ecem","family":"Dal-Bekar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Siomek-Gorecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Gackowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aydan","family":"K\u00f6ken-Av\u015far","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Handan","family":"Yarkan-Tu\u011fsal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merih","family":"Birlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00fcray","family":"\u0130\u015flekel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2022.108997_bb0005","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.patbio.2015.03.003","article-title":"Cellular and molecular mechanisms in the pathophysiology of systemic sclerosis","volume":"63","author":"Hua-Huy","year":"2015","journal-title":"Pathol. Biol. (Paris)"},{"key":"10.1016\/j.clim.2022.108997_bb0010","first-page":"1","article-title":"Whole-genome bisulfite sequencing in systemic sclerosis provides novel targets to understand disease pathogenesis","volume":"12","author":"Lu","year":"2019","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.clim.2022.108997_bb0015","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.humimm.2018.01.003","article-title":"Epigenetics and pathogenesis of systemic sclerosis; the ins and outs","volume":"79","author":"Aslani","year":"2018","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.clim.2022.108997_bb0020","first-page":"1759","article-title":"Epigenetics, the holy grail in the pathogenesis of systemic sclerosis","volume":"54","author":"Altorok","year":"2015","journal-title":"Rheumatol. (United Kingdom)"},{"key":"10.1016\/j.clim.2022.108997_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/7342472","article-title":"Integration of genome-wide DNA methylation and transcription uncovered aberrant methylation-regulated genes and pathways in the peripheral blood mononuclear cells of systemic sclerosis","volume":"2018","author":"Zhu","year":"2018","journal-title":"Int. J. Rheumatol."},{"key":"10.1016\/j.clim.2022.108997_bb0030","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.jid.2017.12.003","article-title":"Genome-wide DNA methylation analysis in systemic sclerosis reveals hypomethylation of IFN-associated genes in CD4+ and CD8+ T cells","volume":"138","author":"Ding","year":"2018","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2022.108997_bb0035","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.mrrev.2016.02.001","article-title":"Enigmatic 5-hydroxymethyluracil: oxidatively modified base, epigenetic mark or both?","volume":"767","author":"Olinski","year":"2016","journal-title":"Mutat. Res. Rev. Mutat. Res."},{"key":"10.1016\/j.clim.2022.108997_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0188856","article-title":"Profiles of a broad spectrum of epigenetic DNA modifications in normal and malignant human cell lines: proliferation rate is not the major factor responsible for the 5-hydroxymethyl-2\u2032-deoxycytidine level in cultured cancerous cell lines","volume":"12","author":"Foksinski","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2022.108997_bb0045","first-page":"1","article-title":"The role of epigenetic modifications in systemic sclerosis: a druggable target","author":"Henderson","year":"2019","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.clim.2022.108997_bb0050","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1586\/eci.11.37","article-title":"Epigenetic modifications: novel therapeutic strategies for systemic sclerosis?","volume":"7","author":"J\u00fcngel","year":"2011","journal-title":"Expert. Rev. Clin. Immunol."},{"issue":"2013","key":"10.1016\/j.clim.2022.108997_bb0055","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"classification criteria for systemic sclerosis: an american college of rheumatology\/European league against rheumatism collaborative initiative","volume":"65","author":"Van Den Hoogen","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2022.108997_bb0060","first-page":"1520","article-title":"High resolution computed tomography in early scleroderma lung disease","volume":"18","author":"Warrick","year":"1991","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2022.108997_bb0065","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41584-018-0099-0","article-title":"New insights into the genetics and epigenetics of systemic sclerosis","volume":"14","author":"Angiolilli","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.clim.2022.108997_bb0070","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/03009740902758875","article-title":"Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis","volume":"38","author":"Lei","year":"2009","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.clim.2022.108997_bb0075","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/exd.12767","article-title":"Global DNA hypomethylation and hypoxia-induced expression of the ten eleven translocation (TET) family, TET1, in scleroderma fibroblasts","volume":"24","author":"Hattori","year":"2015","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.clim.2022.108997_bb0080","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2217\/epi-2016-0150","article-title":"Epigenetic factors as drivers of fibrosis in systemic sclerosis","volume":"9","author":"Bergmann","year":"2017","journal-title":"Epigenomics"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166162200078X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166162200078X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:02:56Z","timestamp":1778616176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152166162200078X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":16,"alternative-id":["S152166162200078X"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2022.108997","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global hypomethylation pattern in systemic sclerosis: An application for absolute quantification of epigenetic DNA modification products by 2D-UPLC-MS\/MS","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2022.108997","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108997"}}